Results 1 to 10 of about 161,849 (206)

Helicobacter trogontum Bacteremia and Lower Limb Skin Lesion in a Patient with X-Linked Agammaglobulinemia—A Case Report and Review of the Literature [PDF]

open access: greenPathogens, 2022
We describe the first case of infection with Helicobacter trogontum in a patient with X-linked agammaglobulinemia. A 22-year-old male with X-linked agammaglobulinemia presented with fever, malaise and a painful skin lesion on the lower left extremity ...
Lasse Fjordside   +4 more
doaj   +5 more sources

Novel BTK Mutation in Patient with Late Diagnosis of X-Linked Agammaglobulinemia [PDF]

open access: goldCase Reports in Immunology, 2023
X-linked agammaglobulinemia (XLA) is a genetic disorder with mutation in Bruton’s tyrosine kinase (BTK). Defects in B cell development and immunoglobulin production lead to recurrent infections following loss of maternal IgG at 6 months of age. A 55-year-
Amanpreet Kalkat   +2 more
doaj   +5 more sources

Case report of renal manifestations in X-linked agammaglobulinemia [PDF]

open access: yesFrontiers in Immunology
IntroductionX-linked agammaglobulinemia (XLA) is a humoral immunodeficiency disorder characterized by recurrent infections, severe hypogammaglobulinemia, and a deficiency of circulating B cells. While the hallmark clinical manifestations of XLA typically
Shuisen Wan   +5 more
doaj   +3 more sources

Co-Occurring X-Linked Agammaglobulinemia and X-Linked Chronic Granulomatous Disease: Two Isolated Pathogenic Variants in One Patient [PDF]

open access: yesBiomedicines, 2023
We present a unique and unusual case of a male patient diagnosed with two coexisting and typically unassociated X-linked conditions: he was initially diagnosed with X-linked agammaglobulinemia (XLA) followed by a diagnosis of X-linked chronic ...
Lauren Gunderman   +6 more
doaj   +3 more sources

The dilemma of X-linked agammaglobulinemia carriers [PDF]

open access: yesJournal of Allergy and Clinical Immunology: Global
Background: Many patients with X-linked agammaglobulinemia (XLA) nowadays have reached adulthood, as well as their sisters, possibly carriers of a deleterious Bruton tyrosine kinase variant. Studies on motherhood outcomes in families with XLA are lacking.
Federica Pulvirenti, MD, PhD   +19 more
doaj   +4 more sources

Mycoplasma pneumonia in a patient with X-linked agammaglobulinemia [PDF]

open access: yesBMC Infectious Diseases
Background X-linked agammaglobulinemia (XLA), also referred to as Bruton’s tyrosine kinase deficiency, is a rare genetic disorder that affects the immune system.
Bowen Dai   +15 more
doaj   +4 more sources

Cytomegalovirus Pneumonia in a Patient with X-Linked Agammaglobulinemia: A Case Report [PDF]

open access: yesMedicina, 2022
X-linked agammaglobulinemia (XLA) is a hereditary immune disorder that predisposes patients to frequent and severe bacterial infections caused by encapsulated bacteria (such as Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae).
Yao-Xian Wong, Shyh-Dar Shyur
doaj   +3 more sources

Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia [PDF]

open access: yesFrontiers in Immunology, 2023
BackgroundBruton’s tyrosine kinase (BTK) is a cytoplasmic protein involved in the B cell development. X-linked agammaglobulinemia (XLA) is caused by mutation in the BTK gene, which results in very low or absent B cells.
Chai Teng Chear   +17 more
doaj   +3 more sources

IgA nephropathy in a child with X-linked agammaglobulinemia: a case report [PDF]

open access: yesBMC Pediatrics
Background X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disease caused by mutations in the Bruton tyrosine kinase (BTK) gene. Individuals diagnosed with XLA are at an increased risk of developing autoimmune diseases.
Yuanjin Song   +4 more
doaj   +3 more sources

A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma. [PDF]

open access: bronzeJ Clin Immunol, 2021
To the Editor: Over the past year, the coronavirus disease 2019 (COVID19) has resulted in a worldwide pandemic. The disease results in a wide range of clinical presentations that range from asymptomatic to respiratory failure and death. To date, only two
Iaboni A, Wong N, Betschel SD.
europepmc   +4 more sources

Home - About - Disclaimer - Privacy